Major change to smear tests as women 'spared appointments they don't need'
Cervical cancer screenings will be less common for women aged 25 to 49 if they are shown to be low risk - low risk individuals will be able to wait five years between smear tests
A major change to cervical cancer screening will mean younger women can have the smear test less often. Women aged 25 to 49 will no longer have to be tested every three years if their previous test shows no signs of the human papillomavirus (HPV), which is linked to cervical cancer.
These women deemed at low risk will be able to wait five years between smear tests after the Joint Commission on Vaccination and Immunisation advised that this is safe. The change will come into force from next month. Dr Sue Mann, NHS national clinical director for women's health, said: 'Taking a more personalised approach to cervical screening will help ensure everyone eligible can make the most of these life-saving services, while sparing women appointments that they don't need.'
Two people a day still die from cervical cancer in the UK and the disease claimed the life of Celebrity Big brother star Jade Goody in 2009.
The move follows a recommendation by the UK National Screening Committee the five-year interval brings younger women into line with the approach already used for women aged 50 to 64 in England.
Michelle Mitchell, chief executive of Cancer Research UK, said: "We welcome this change to cervical screening in England, which is the result of years of vital research to make screening more effective and has shown it is safe to extend the time between tests. Screening, alongside the roll out of the HPV vaccine have seen cervical cancer rates drop by around a quarter since the early 1990s, and we look forward to even more progress.
"Beating cervical cancer means beating it for all, and we're committed to a future where almost no one develops this disease. If you notice any unusual changes for you, do not wait for a screening invitation - speak to your doctor." Currently cervical screening involves a medical professional inserting a soft brush to take a sample of cells from the cervix.
In recent years cervical cancer rates have dropped for women in their 20s who received the HPV vaccine, but have increased for women aged 30 to 44.
NHS England data shows that during 2023/24 only 68.8% of 25 to 64-year-olds were screened within the recommended period of time, compared to 68.7% the previous year. Embarrassment is thought to be a major reason uptake of screening is not higher and rates have fallen in recent years.
The NHS has this week rolled-out digital invitations and reminders for cervical screening via the NHS App, as part of a new 'ping and book' service. Eligible women will first receive a notification through the app to alert them to book a screening appointment, followed by a text message if the app notification isn't opened. Letters will remain in place for those who need them.
Dr Mann added: 'The NHS is following robust evidence on how often women need to be safely screened and by putting invitations and reminders straight in women's pockets on their phones, we're making it easier than ever to take up screening appointments.'
Currently all women aged 25 to 64 are invited by letter to cervical screening to check the health of their cervix. It is not a test for cancer but looks for abnormal cells to help prevent cancer.
A small sample of cells is taken from the cervix and checked for certain types of human papillomavirus (HPV) that can cause changes to the cells of your cervix. These are called "high risk" types of HPV.
If these types of HPV are found, the sample is checked for any changes in the cells of your cervix. These can be treated before they get a chance to turn into cervical cancer.
Cervical cancer causes 685 deaths a year in England. The move to five-year intervals for younger women brings England into line with Scotland and Wales.
Louise Ansari, chief executive of Healthwatch England, said: "We welcome this change, which confirms that most women will not need to attend screening so frequently.
'Healthwatch research last year showed many women can find it an uncomfortable experience, and sometimes difficult to schedule in around their busy lives. Reducing the number of times they need to attend, alongside sensitive and empathetic approaches by health professionals, will make these important appointments easier to manage.'
Women due for screening will still be invited at the interval in which they were advised of at the time of their last test. Only those who attend cervical screening on or after 1 July, and meet the clinical criteria, will have their next test due date set at five years.
The NHS aims to eliminate cervical cancer by 2040 and is also rolling out the option of DIY swab kits. The World Health Organisation's definition of eliminating cervical cancer is to have an incidence rate of below 4 per 100,000 women.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
36 minutes ago
- Daily Mail
UK Pharmaceutical industry at risk from government's 'sky-high' rebates system
The UK's status as a leader in medical research is at risk from 'sky-high and unpredictable' repayments pharmaceutical firms hand the Government, says an industry boss. Richard Torbett, chief executive of the Association of the British Pharmaceutical Industry, said the rebate system – where firms repay money they make through selling medicines to the NHS – was sending 'a terrible message to international investors'. Rachel Reeves promised to support 'the UK's strengths in life sciences' and 'ensure patients get rapid access to the most clinically and cost-effective new technologies'. The Treasury plans to invest up to £520million in drug manufacturing in the next five years. Another £600million is earmarked for a health data research service to accelerate the discovery of new medicines. But Torbett said more was needed. 'Over the past decade, accounting for inflation, the NHS budget has grown by a third in real terms, while investment in the most rigorously cost-benefit-tested part of health spending – investment in the medicines needed to treat people – has fallen from around 11 per cent to 9 per cent of the health budget,' he added. And he attacked plans to increase what drug companies must repay from drug sales to 31.3 per cent, from 15.5 per cent. 'The sky-high and unpredictable payment rates send a terrible message to international investors when the UK is trying to position life sciences research and development as an engine for health and growth. For the sake of patients, the NHS and the economy, we need a commitment to bring these unsustainable rates down.'
The Independent
2 hours ago
- The Independent
Government can hit NHS waiting times targets despite scepticism, says Reeves
The Chancellor has insisted the Government can hit its NHS waiting times targets despite scepticism from some leaders. Speaking after her spending review, Rachel Reeves said the Government was confident it could hit pledges set down by the Prime Minister last year. Sir Keir Starmer said in December the NHS will carry out 92% of routine operations within 18 weeks by March 2029. However, in March this year, the NHS waiting list for hospital treatment in England rose for the first time in seven months. The Times has also reported that internal Department of Health modelling shows the NHS is on course to hit only about 80% by the end of the parliament, with officials suggesting anything above that is overly optimistic. Asked about the pledge on Wednesday afternoon, Ms Reeves told reporters: 'We've already delivered around three-and-a-half million additional appointments since we came to office last July. 'Waiting lists are already down by 200,000 so we are confident that we can meet our plan for change commitments because of the 3% annual increase in funding for the National Health Service. 'On top of that of course, we're investing in capital spending in the NHS, including in more scanners, but also investment in the NHS digital app to make it easier for patients to access information, to book services, to take some of the costs out of the bureaucracy, as well in running our health service.' Earlier, the 3% increase in real terms for the health service per year in the spending review was welcomed by health leaders but there were warnings it is not enough. Matthew Taylor, chief executive of the NHS Confederation, which represents all health organisations, said the NHS funding boost was welcome, 'given the precarious state of public finances and will help the NHS to cope with rising demand from an aging population, often with multiple or more complex physical and mental health conditions'. But he warned 'difficult decisions will still need to be made as this additional £29 billion won't be enough to cover the increasing cost of new treatments, with staff pay likely to account for a large proportion of it'. He added: 'So, on its own, this won't guarantee that waiting time targets are met.' Mr Taylor said NHS leaders will need continued backing from the Government to redesign services and balance budgets. 'That means getting political backing when some services are redesigned or cut, including moving hospital services into the community and closer to people's homes as part of the Government's three shifts,' he said. He added that the 'flat settlement' from the Chancellor 'continues to leave a major shortfall in capital funding, and it also fails to lift the ban on private investment that is required to boost NHS capital funding'. There is currently an almost £14 billion maintenance backlog bill to repair NHS hospitals and buildings. Mr Taylor said those issues needed to be addressed in the upcoming national infrastructure strategy and 10-year plan for the health service. Government documents accompanying the spending review show that, on average, from 2023-24 to 2028-29, the NHS in England will receive 3% real terms growth in day-to-day spending, equivalent to a £29 billion real terms increase in annual budgets. The Department of Health and Social Care (DHSC) budget will increase by £2.3 billion in real terms by 2029-30, compared with 2023-24, 'representing a more than 20% real terms increase by the end of the spending review period', the documents said. Overall, the figures suggest DHSC spending will rise 2.8%, though this is less than the average 3.6% in recent years. Sarah Woolnough, chief executive of the King's Fund charity, said the 2.8% average increase in DHSC spending – or 3% for day-to-day NHS spending – 'will have been hard-fought for in the spending round negotiations, despite still being lower than the historical average the NHS has received over recent years'. She added: 'We know there are already trade-offs happening in the NHS due to tight finances. 'The Chancellor said she wants the public to have an NHS there when they need it. 'It is hard to see how all the things she mentions: faster ambulance times; more GP appointments; and adequate mental health services and more; can be met on this settlement alone. 'Particularly when large parts of this additional funding will be absorbed by existing rising costs, such as the higher cost of medicines, which are currently being negotiated, and covering staff pay deals.' According to spending review documents, the Government expects the NHS to deliver 2% productivity growth each year, 'unlocking £17 billion savings over three years' to reinvest back into the NHS to improve patient care. The Government will also invest up to £10 billion in NHS technology and digital transformation by 2028‑29, the documents showed. NHS England boss Sir Jim Mackey, speaking at the NHS ConfedExpo conference in Manchester, said the NHS has done 'really well relative to other parts of the public service'. He added: 'But we all know it's never enough because of the scale of advancement, all the ambition, all things we want to do, the day-to-day cost pressures we're trying to get on top of, etc. 'We're always going to be in a world where we want more money, but I think everyone's starting to accept and understand that we've got what the country can afford to give us. 'We really need to get better value for that money – it is broadly the equivalent of the GDP of Portugal, so it's a huge amount of money by any standards.' NHS England has already budgeted a 2.8% increase in pay for staff in 2025-26, but many leaders the King's Fund spoke to were worried about funding pay rises above this amount. After the spending review, Royal College of Nursing (RCN) general secretary, Professor Nicola Ranger, said staff will now decide whether the 3.6% pay rise offered by the Government is enough. She added: 'Against a backdrop of other cuts, nursing staff will see the NHS being protected but not transformed by today's spending plans. 'When the Government lays out its vision for the future of the NHS and its workforce, it must say how it intends to reverse collapsing student recruitment, boost retention and deliver urgent, structural reform to nursing pay.' Nuffield Trust senior policy analyst, Sally Gainsbury, said: 'Compared to the settlements for other departments – from policing to education – the NHS deal looks generous. 'But seen in the context of all the promises made by the Government to the British people – to drive down waiting lists, shift care closer to home, rapidly improve tech – and the commitments to meet staff pay demands and rising costs of new drugs, today's settlement soon melts away. 'With capital funding staying flat in real terms for the rest of the spending review period, it will be difficult for the NHS to invest in the technology and facility upgrades it needs to meet the Government's ambitious productivity targets.'
North Wales Chronicle
2 hours ago
- North Wales Chronicle
NHS should ‘tear up the outpatient model'
Around 130,000,000 outpatient appointments – procedures or appointments which take place in hospitals or clinics but do not require an overnight stay – take place in the NHS in England every year. The majority of people on the NHS waiting list are waiting for outpatient appointments. An estimated 7.42 million treatments were waiting to be carried out at the end of March, relating to 6.25 million patients, according to official figures. The latest performance figures for the NHS in England are due to be published on Thursday. Sir Jim Mackey, chief executive of NHS England, told the NHS ConfedExpo conference that the service should take 'big leaps' such as 'tearing up the outpatient model' and 'tearing up the frustrations about technology' and 'tearing up the multiple touch points for patients when it should be one'. And Dr Penny Dash, chairwoman of NHS England, told delegates: 'There are seven and a half million people on the waiting list, half of them waiting more than 18 weeks, and the majority of those people waiting for an outpatient appointment. 'Surely we can fix outpatients to help bring down the waiting list.' Matthew Taylor, chief executive of the NHS Confederation, said: 'Outpatient services should and could be transformed with most checks and follow-ups done in neighbourhoods or remotely.' Meanwhile, Sir Jim said the NHS has 'lost its way' on quality of care, as he told delegates that the forthcoming 10-year plan for health, which is to be published in July, will 'focus on quality'. 'Neighbourhood care – I think that part of the plan is still a really big standout for me,' he said. 'The focus on quality, I think it's really welcome – we have lost our way a little bit on quality coming out of Covid, and again, looking at quality in the round and not just safety.' But he said that the NHS would move on from the 'over-prescription centrally' and the 'labyrinthine approval processes' to give local health leaders more freedom. Dr Dash added: 'We do need to have a comprehensive strategy for quality. 'We've had a big focus on safety, rightly, over the last 10 years, but that has been a bit at the expense of patient experience and also effectiveness. We need to regroup, set out that strategy.'
